Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
7.19
+0.84 (13.23%)
Nov 6, 2026, 4:00 PM EST - Market closed
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of $152.3 million as of November 6, 2026. Its market cap has increased by 65.65% in one year.
Market Cap
152.30M
Enterprise Value
90.01M
1-Year Change
65.65%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from $45.99M to $152.30M, an increase of 231.15%. That is a compound annual growth rate of 25.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 152.30M | 70.56% |
| Dec 31, 2025 | 89.30M | -6.65% |
| Dec 31, 2024 | 95.65M | 160.46% |
| Dec 29, 2023 | 36.73M | 440.53% |
| Dec 30, 2022 | 6.79M | -73.94% |
| Dec 31, 2021 | 26.07M | -43.31% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 163.56M |
| Zentalis Pharmaceuticals | 162.84M |
| Oramed Pharmaceuticals | 160.57M |
| ALX Oncology Holdings | 159.71M |
| Sutro Biopharma | 159.51M |
| AN2 Therapeutics | 150.94M |
| MacroGenics | 148.42M |
| Sionna Therapeutics | 148.30M |